X hits on this document

216 views

0 shares

0 downloads

0 comments

4 / 81

11-12, 2005

21.

Does the type of DM influence the prevalence of NASH

Falk Symposium No 150, Berlin, October 3-4, 2005

A.Goldiş, C. Vernic, D. Lazăr

22.

Clinical and pathological significance of hepatic steatosis in chronic hepatitis C virus infection

Falk Symposium No 150, Berlin, October 3-4, 2005

D.Lazăr, M. Cornianu, A. Goldiş, S. Tăban, CA Salha.

23.

Epidemiological aspects of diverticular disiases

Falk Symposium No 148, Munich, June 17-18, 2005

A.Goldiş, V. Lungu

24.

Key elements in the diagnosis, treatment strategies and management of Irritable Bowel Syndrome (IBS) in 2004. Results of an international survey

IBS Forum No.2, Mayoly Spindler Laboratories 2005

M. Dapoigny, B. Coffin, A. Goldiş, et all

25.

Fibrosis rate – usefull predictor of response rate to antiviral therapy in chronic C hepatitis.

WCOG Montreal, Canada 2005

Străin M.

26.

Vascular dementia, risk factors of progression

9th Congress of the European Federation of Neurological Societies, Atena, 17-20 sept, 2005

Scutelnicu, Dorina, Pleşa Adina

27.

Clinical-cytogenetic aspects related to mosaicism in the variants of Turner syndrome

EUR. J. Of HUMAN GENETICS, 2005, 13, suppl. 1, revista ISI

C. Mihaescu, C. Crista, I. Zosin, D. Stoicanescu, V. Belengeanu

28.

Does calcium and vitamin D alter bone turnover and the levels of calciotropic hormones?

European Congress of Endocrinology, 3-7 sept. 2005, Göteburg, Suedia

Ioana Zosin, Melania Balaş, Ioana Golu, Oana Simon

29.

The contribution of the forensic expert to the prevention of carbon monoxide (CO) intoxication

42th Congress of European Toxicology, 11-14 sept, Cracow Poland, 2005. ISSN 0378-4274

Enache A., Petcu M., Baboiu OE, Belei V., Chatzinikolaou F.

Document info
Document views216
Page views216
Page last viewedThu Dec 08 18:16:13 UTC 2016
Pages81
Paragraphs2567
Words22238

Comments